Mogens T Hansen

Title: Mogens T Hansen: Innovator in Biosynthetic Insulin

Introduction

Mogens T Hansen is a notable inventor based in Olstykke, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of biosynthetic insulin precursors. With a total of 2 patents, his work has had a profound impact on medical science.

Latest Patents

Hansen's latest patents include a DNA-sequence encoding biosynthetic insulin precursors and a process for human insulin precursors. The invention involves preparing human insulin precursors that contain the peptide chain B(1-29)-A(1-21) of human insulin, along with derivatives that feature a bridging chain. This bridging chain connects the carboxyl terminus of the B(1-29)-chain with the amino terminus of the A(1-21)-chain. The process utilizes a yeast host transformed with a replicable expression vehicle capable of expressing the DNA-sequence encoding the insulin precursor. Additionally, he has developed a process for preparing glucagon or its fragments and derivatives through the cultivation of a yeast strain transformed with a gene encoding the expression of such products.

Career Highlights

Mogens T Hansen has had a distinguished career at Novo Industri A/S, where he has been instrumental in advancing research in insulin production. His innovative approaches have contributed to the efficiency and effectiveness of insulin synthesis, which is crucial for diabetes management.

Collaborations

Hansen has collaborated with notable colleagues such as Kjeld Norris and Lars Thim, enhancing the research and development efforts within his field.

Conclusion

Mogens T Hansen's contributions to the field of biotechnology, particularly in the area of biosynthetic insulin, highlight his role as a leading inventor. His patents and collaborative efforts continue to influence advancements in medical science.